First Citizens Financial Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Sell
5,199
-315
-6% -$67.8K 0.55% 49
2026
Q1
$1.2M Buy
5,514
+200
+4% +$44.4K 0.57% 49
2025
Q4
$1.21M Sell
5,314
-365
-6% -$83.1K 0.6% 47
2025
Q3
$1.31M Sell
5,679
-2
-0% -$407 0.65% 45
2025
Q2
$1.05M Hold
5,681
0.58% 47
2025
Q1
$1.19M Sell
5,681
-21
-0.4% -$4.08K 0.67% 42
2024
Q4
$1.01M Sell
5,702
-75
-1% -$13.8K 0.55% 44
2024
Q3
$1.14M Buy
5,777
+53
+0.9% +$9.89K 0.6% 43
2024
Q2
$982K Sell
5,724
-115
-2% -$19.1K 0.58% 45
2024
Q1
$1.06M Buy
5,839
+24
+0.4% +$4.14K 0.63% 42
2023
Q4
$901K Hold
5,815
0.58% 43
2023
Q3
$867K Hold
5,815
0.61% 38
2023
Q2
$783K Buy
+5,815
New +$853K 0.53% 39
2022
Q4
$728K Buy
4,505
+100
+2% +$15.3K 0.63% 38
2022
Q3
$591K Sell
4,405
-100
-2% -$14.3K 0.58% 38
2022
Q2
$690K Buy
4,505
+315
+8% +$48.1K 0.61% 35
2022
Q1
$679K Hold
4,190
0.51% 39
2021
Q4
$567K Hold
4,190
0.41% 47
2021
Q3
$452K Sell
4,190
-5
-0.1% -$571 0.36% 51
2021
Q2
$473K Sell
4,195
-224
-5% -$25.2K 0.36% 54
2021
Q1
$478K Sell
4,419
-311
-7% -$33.3K 0.39% 50
2020
Q4
$507K Sell
4,730
-230
-5% -$22.1K 0.44% 45
2020
Q3
$434K Sell
4,960
-26
-0.5% -$2.45K 0.43% 45
2020
Q2
$490K Sell
4,986
-54
-1% -$4.75K 0.51% 41
2020
Q1
$384K Buy
5,040
+90
+2% +$7.67K 0.5% 42
2019
Q4
$438K Buy
+4,950
New +$411K 0.43% 46

Other funds holding ABBV

First Citizens Financial Corp's ABBV Position: Q2 2026 in Review

First Citizens Financial Corp reduced its AbbVie (ABBV) stake by 5.7% in Q2 2026, selling an estimated $67.8K and leaving 5,199 shares worth $1.31M. The position accounts for 0.55% of the portfolio, ranked #49.

First Citizens Financial Corp first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.31M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Citizens Financial Corp held 5,199 shares of AbbVie worth $1.31M as of Q2 2026.
  • First Citizens Financial Corp sold 315 AbbVie shares in Q2 2026, an estimated $67.8K.
  • AbbVie made up 0.55% of First Citizens Financial Corp's portfolio in Q2 2026, its #49 holding.
  • First Citizens Financial Corp first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • First Citizens Financial Corp's AbbVie position peaked at $1.31M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Citizens Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.